3D Systems Corp Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
Analyst Coverage
2analysts covering
FY Revenue (est.)
$389.3Mnext fiscal year
FY EPS (est.)
-$0.15next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release | 9 Nov 2026 |
Monitoring Framework
Key Performance Indicators
Healthcare Segment Revenue Growth Quarterly2,100.0%Target: Sustained double-digit growth to offset industrial segment declines
Adjusted EBITDA Quarterly2.1MTarget: Full-year break-even Adjusted EBITDA
Total Cash and Cash Equivalents Quarterly86.5MTarget: Maintain sufficient liquidity to avoid near-term capital raises
Watch Items
- Industrial Segment Revenue DeclineTrigger: Year-over-year decline exceeding 15%Action: Re-evaluate cost structure and accelerate transition of resources to Healthcare and Aerospace & Defense segments
- Dilution and Capital RaisesTrigger: Cash burn rate threatening to deplete cash reserves below $50 million before mid-2027Action: Assess the impact of serial equity issuances on shareholder value and adjust the investment rating accordingly
Research as of 20 Jun 2026